Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 4
1983 1
1984 1
1985 2
1986 5
1987 7
1988 6
1989 4
1990 1
1991 5
1992 11
1993 8
1994 8
1995 14
1996 20
1997 23
1998 14
1999 19
2000 16
2001 33
2002 47
2003 37
2004 71
2005 114
2006 105
2007 129
2008 130
2009 175
2010 215
2011 248
2012 343
2013 394
2014 478
2015 567
2016 638
2017 662
2018 789
2019 982
2020 1078
2021 1252
2022 1124
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

8,791 results
Results by year
Filters applied: . Clear all
Page 1
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K Jr, Grosskurth SE, Vijay P, Ghosh S, Lu C, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE, Battula VL, Mi Y, Wang J, DiNardo CD, Andreeff M, Tyner JW, Schimmer A, Letai A, Padua RA, Bueso-Ramos CE, Tiziani S, Leverson J, Popovic R, Konopleva M. Zhang Q, et al. Among authors: jia y. Signal Transduct Target Ther. 2022 Feb 21;7(1):51. doi: 10.1038/s41392-021-00870-3. Signal Transduct Target Ther. 2022. PMID: 35185150 Free PMC article.
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening.
He YQ, Wang TM, Ji M, Mai ZM, Tang M, Wang R, Zhou Y, Zheng Y, Xiao R, Yang D, Wu Z, Deng C, Zhang J, Xue W, Dong S, Zhan J, Cai Y, Li F, Wu B, Liao Y, Zhou T, Zheng M, Jia Y, Li D, Cao L, Yuan L, Zhang W, Luo L, Tong X, Wu Y, Li X, Zhang P, Zheng X, Zhang S, Hu Y, Qin W, Deng B, Liang X, Fan P, Feng Y, Song J, Xie SH, Chang ET, Zhang Z, Huang G, Xu M, Feng L, Jin G, Bei J, Cao S, Liu Q, Kozlakidis Z, Mai H, Sun Y, Ma J, Hu Z, Liu J, Lung ML, Adami HO, Shen H, Ye W, Lam TH, Zeng YX, Jia WH. He YQ, et al. Among authors: jia y. Nat Commun. 2022 Apr 12;13(1):1966. doi: 10.1038/s41467-022-29570-4. Nat Commun. 2022. PMID: 35414057 Free PMC article.
Retraction Notice to: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment.
Xiong H, Chen Z, Lin B, Chen W, Li Q, Li Y, Fang M, Wang Y, Zhang H, Lu Y, Bi A, Wu S, Jia Y, Wang X. Xiong H, et al. Among authors: jia y. Mol Ther Oncolytics. 2022 May 10;25:263. doi: 10.1016/j.omto.2022.05.002. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35615267 Free PMC article.
LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z, Zhong C, Shen J, Jia Y, Duan S. Xie Z, et al. Among authors: jia y. Biomed Pharmacother. 2022 Jun;150:113019. doi: 10.1016/j.biopha.2022.113019. Epub 2022 Apr 21. Biomed Pharmacother. 2022. PMID: 35462329 Free article. Review.
NiH-catalyzed dearomative hydroalkylation of indoles.
Liu K, Song YF, Gao Y, Luo JQ, Jia YX. Liu K, et al. Among authors: jia yx. Chem Commun (Camb). 2022 May 12;58(39):5893-5896. doi: 10.1039/d2cc01650h. Chem Commun (Camb). 2022. PMID: 35474004
8,791 results